Takeda Pharmaceuticals CONTRAVE recall — FDA D-1206-2015
Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.
Overview of recall records associated with Takeda Pharmaceuticals North America, Inc., including dates, categories and classifications where available.
Classification mix: Class II: 1.
Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.
This page summarizes recall records in which the official source identifies Takeda Pharmaceuticals North America, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.